Language Settings
My query is:

Combine searches by placing the search numbers in the top search box and pressing the search button.
An example search might look like (#1 or #2) and (#3 or #4)

Loading history...

Latest & greatest articles for anticoagulation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on anticoagulation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on anticoagulation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for anticoagulation

1. Direct acting oral anticoagulants likely to be better than warfarin for people taking them for atrial fibrillation

NIHR Dissemination Centre2018

2. Screen reminders for GPs did not improve anticoagulant prescribing in atrial fibrillation

NIHR Dissemination Centre2018

3. Extending anticoagulant treatment beyond three months reduces the risk of recurrent blood clots

NIHR Dissemination Centre2018

4. New generation anticoagulants may be safer than warfarin for people with chronic kidney disease

NIHR Dissemination Centre2018

5. An anticoagulant, bivalirudin, may not be safer than the alternative, heparin, when unblocking arteries in the heart

NIHR Dissemination Centre2018

6. Screen reminders for GPs did not improve anticoagulant prescribing in atrial fibrillation

NIHR Dissemination Centre2018

7. New generation anticoagulants may be safer than warfarin for people with chronic kidney disease

NIHR Dissemination Centre2018

8. An anticoagulant, bivalirudin, may not be safer than the alternative, heparin, when unblocking arteries in the heart

NIHR Dissemination Centre2018

9. Extending anticoagulant treatment beyond three months reduces the risk of recurrent blood clots

NIHR Dissemination Centre2018

10. Blood and Clots Series: When can patients on direct anticoagulants have surgery?

CandiEM2018

11. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines?Anticoagulation During Cardiopulmonary Bypass

Society of Thoracic Surgeons2018

12. Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury

EvidenceUpdates2018

13. Direct acting oral anticoagulants likely to be better than warfarin for people taking them for atrial fibrillation

NIHR Dissemination Centre2018

14. Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.

BMJ2018

15. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.

JAMA2018

16. Direct oral anticoagulants or warfarin for A fib?

PURLS2018

17. Meta-Analysis of the Safety and Efficacy of the Oral Anticoagulant Agents (Apixaban, Rivaroxaban, Dabigatran) in Patients With Acute Coronary Syndrome

EvidenceUpdates2018

18. Less dementia with oral anticoagulation in atrial fibrillation

EvidenceUpdates2018

19. Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation

EvidenceUpdates2017

20. Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study.

BMJ2017